Zilia

Artificial Intelligence, Health Diagnostics, Medical Device
Founded in 4/1/12
Quebec, Quebec, Canada
For Profit

About Zilia

Zilia has developed a non-invasive platform technology that uses imaging, spectrometry and artificial intelligence to quantitatively measure different biomarkers in the human eye. Zilia’s initial product, Zilia Ocular, is the first retinal camera to quantify oxygen saturation, a crucial biomarker in ocular diseases such as glaucoma, DR and AMD. Zilia aims to revolutionize the prevention, diagnosis and management of these diseases by generating actionable data about the eye’s metabolic activity.

Company Metrics

  • Employees: 11-50
  • Monthly Visits: 9983
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue:
  • Total Funding: 4000000 CAD
  • Last Funding: 4000000 CAD (Seed)
  • Funding Status: Seed

Technology Stack

Zilia actively uses None products in their tech stack.

Market Presence

Industries: Artificial Intelligence, Health Diagnostics, Medical Device

Headquarters: Quebec, Quebec, Canada